H. Giles et al., CHARACTERIZATION OF A 5-HT1B RECEPTOR ON CHO CELLS - FUNCTIONAL-RESPONSES IN THE ABSENCE OF RADIOLIGAND BINDING, British Journal of Pharmacology, 117(6), 1996, pp. 1119-1126
1 Chinese hamster ovary (CHO) cells have been reported to be devoid of
5-HT receptors and have frequently been used as hosts for the express
ion of cloned 5-HT receptors. Unexpectedly, 5-HT was found to induce p
rofound inhibition of forskolin-stimulated cyclic AMP production in th
ese cells and the aim of this study was to classify the 5-HT receptor
involved. 2 In CHO(dhfr-) cells 5-HT was a potent agonist and caused 8
0-100% inhibition of forskolin stimulated cyclic AMP production. A stu
dy using several 5-HT, receptor agonists revealed the following potenc
ies (p[A(50)]): RU24969 (9.09 +/- 0.17) > 5-carboxamidotryptamine (8.8
6 +/- 0.20) > 5-HT (8.07 +/- 0.05) > CP-93,129 (7.74 +/- 0.10) > sumat
riptan (5.93 +/- 0.04). All five agonists achieved a similar maximum e
ffect. Irreversible receptor alkylation studies yielded a pK(A) estima
te of 7.04 +/- 0.34 for 5-HT. 3 The 5-HT1A/1B antagonist, (+/-)-cyanop
indolol (4-100 nM), caused parallel rightward shifts of the 5-HT conce
ntration-effect curve with no change in asymptote. Schild analysis yie
lded a pK(B) estimate of 8.69 +/- 0.09 (Schild slope 1.13 +/- 0.10). (
+/-)-Cyanopindolol actually behaved as a partial agonist with an intri
nsic activity of 0.2-0.5 and a p[A(50)] of 8.55. 4 5-HT (0.01-10 mu M)
also elicited a concentration-dependent increase in intracellular [Ca
2+] in CHO(dhfr-) cells thus demonstrating that dual coupling is not a
phenomenon restricted to systems in which there is overexpression of
transfected receptors. 5 This agonist and antagonist profile is consis
tent with the presence of a 5-HT1B receptor. 8-OH-DPAT (1 mu M) and re
nzapride (3 mu M) were without effect on forskolin-stimulated cyclic A
MP production and ketanserin (0.3 mu M) did not antagonize the inhibit
ion produced by 5-HT, thus excluding the involvement of 5-HT1A, 5-HT4,
and 5-HT2 receptors. 6 The possibility that expression of a 5-HT1B re
ceptor was associated with the dhfr- mutation was excluded since RU249
69, 5-HT and CP-93,129 were also potent agonists in unmutated, CHO-K1
cells: P[A(50)] 9.03 +/- 0.03, 8.34 +/- 0.05, 7.69 +/- 0.07 respective
ly, and (+/-)-cyanopindolol (0.1 mu M) shifted the 5-HT curve to the r
ight and yielded a pA(2) estimate of 8.70 +/- 0.06. 7 Little or no spe
cific binding of [H-3]-5-HT (0.1-200 nM) or of the high affinity ligan
d [I-125]-iodocyanopindolol (0.01-3 nM) to CHO(dhfr-) cell membranes c
ould be detected. 5-HT also failed to elicit any increase in the bindi
ng of [S-35]-GTP gamma S to CHO membranes. 8 In conclusion, cultured C
HO cells express 5-HT1B receptors which are negatively coupled to aden
ylyl cyclase and positively coupled to increases in intracellular calc
ium. The absence of radioligand binding was unexpected in view of the
high potency of 5-HT and the partial agonist activity of the normally
'silent' competitive antagonist, (+/-)-cyanopindolol. This implies ver
y efficient receptor-effector coupling of a low density of 5-HT1B rece
ptors. Clearly, the absence of detectable radioligand binding cannot b
e assumed to mean the absence of receptors capable of eliciting a sign
ificant functional response.